Forgot Password

Flat 25% discount on all reports exclusively for July & August 2018

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4251116
  • Global Glucosamine Market- Technologies, Market share and Industry Forecast to 2024

  • Publish: November 2016 | Report Code: HPH-4251116

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Glucosamine is an amino derivative of glucose. It is the part of polysaccharides and a basic structure unit of chitin. It is highly used in dietary supplements and pharmaceuticals. The global glucosamine market is expected to have the CAGR of 10.9% during period 2016-2023. There is high prevalence of arthritis and joint pain diseases globally which is highly impacting the glucosamine market as glucosamine is an important ingredient of the medicine used for treating joint pain and arthritis diseases. So the rising cases of arthritis diseases will increase the demand for medicines which positively impact the glucosamine market. According to the World Health Organization there are 9.6% of men and 18.0% of women who are aged above 60 years are suffering from symptomatic arthritis. Rising geriatric population is the prime factor driving global glucosamine market for the forecast period. National Institute of Health’s report, An Aging World 2015, estimated the world’s geriatric population (aged 65 and over) to be 8.5% in 2015. The report predicts geriatric population to reach around 17% by 2050.  Men and women above 65 years tend to suffer from arthritis and other joint pain diseases. By the year 2040, more than 78 million people aged 18 years and above will suffer from one or other form of Osteoarthritis (OA). Expenditures towards OA treatment for US government alone costs approx. $62.1billion every year.

Proper disposal and recycling technique, low awareness of glucosamine material in emerging economies, and traceability & control of supply chain are the challenges faced by the key market players in the glucosamine market. Majority doctors prescribe glucosamine to regulate OA disease. Emerging economies like India and China are increasing investments for preventive healthcare for the forecasted period. The glucosamine market is segmented in terms of applications. Dairy product is among the known common application of glucosamine. Glucosamine in dairy products market are estimated to reach $57million by 2020, at CAGR 15%. By 2025, countries like India, Pakistan, US, and China will be leading producers of milk and dairy products growing at 3 % annually.

 

Source: OBRC Analysis

The research report is segmented on the basis of type and applications. On the basis of type, the market segmented into:

  • N- acetyl glucosamine,
  • Glucosamine HCL ,
  • Glucosamine Sulphate ,
  • Glucosamine Acetyl
  • Poly-N-Acetyl-Glucosamine (Poly NAG)  







Under application, the research report is segmented into:

  • Nutritional Supplements
  • Food & Beverage
  • Dairy Products
  • Feed Additives
  • Pharmaceuticals






Food & beverage is one of the fastest rising application segments. Europe and Asia Pacific are the leading regions in food & beverage market. The global demand in food & beverage is expected to have the CAGR of 15% (11,700tons) by 2020. Japan is the fastest rising consumer market for glucosamine in food and beverage. Japan has over 26% of its total population aged 65 years and above. Geriatric population in Japan is estimated to increase at 4% per annum. Glucosamine market in Japan is growing at CAGR 17% till 2020. Nutritional supplement was leading application segment of glucosamine in the world with market share of 35% in 2015. The nutritional supplement market is growing fastest in US. US accounted for the largest market share (of 71%) in North America for glucosamine. Growing geriatric population and health conscious working people are the contributing factors towards nutritional supplement market growth. Nutritional supplement market share of North America was 27% in 2015. Asia Pacific is expected to have the fastest growth rate  for nutritional supplement with CAGR of 12.5% by 2022. Increasing geriatric population in China, Japan, and Australia are the main drivers of nutritional supplement market in Asia Pacific.

The revenue for the above application  segments are specific to the global glucosamine market. however, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type segment. Region wise the glucosamine market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World.





North America dominated the glucosamine market with market share of 32% in 2015. North America is followed closely by Europe with market share of 29% in 2015. Awareness regarding glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the market in North America and Europe for the forecast period. Asia Pacific is the fastest growing glucosamine market for the forecast period and is expected to have market share of 34% by 2022. In 2015, Asia Pacific had over 38% of the world’s total geriatric population. Every five years geriatric population in Asia Pacific grows at 22%. Increasing geriatric population, increasing health conscious working people, rising adoption of food & beverage, and growing vegan population are the factors driving glucosamine market in Asia Pacific for the forecasted period. Geriatric population in India is estimated to increase up to 3.75% by 2021. Countries like Japan, India, China, Indonesia and Vietnam are among the growing markets for glucosamine in Asia Pacific. Nutritional supplements demand is growing in India, with growing awareness among working youth population. Food Safety and Standards Act 2006 and Food & Drug Administration’s Orphan Drug Act Amendments 1988 are the reference points for regulations for food products including nutritional supplements to be sold in the country.

The major market players of the global glucosamine market are:

  • ALFA CHEM,
  • CARGILL INC.
  • FABRICHEM INC.
  • GOLDEN SHELL BIOCHEMICAL CO LTD.
  • KOYO CHEMICAL COMPANY LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.







Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in glucosamine market, to increase their global presence. Example: Frutarom Inc., bought 100% shares of nutritional supplement manufacturer, Grow Company Inc., US, for $20million on 18th January 2016.

On 29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF world’s first non-shellfish glucosamine product. TSI Group Co Ltd has their presence in Europe and North America.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch that is on29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF worlds first non-shellfish glucosamine product
  • Provide in detail description about segments which affect the global glucosamine market.
  • Provide you the patent analysis of the global glucosamine market.
  • Identify and understand the strengths, opportunities, challenges and threats of the glucosamine market.
  • Provide revenues of major players of the market such as Alfa Chem, Cargill Inc, Teva Pharmaceutical Industries Ltd.
  • Provide you various regulatory policies which affect the global glucosamine market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global glucosamin market offers the longest chain of market segmentation covering major market segmentation based on application and type. The report tracks the major market trends in the global glucosamine market such as increasing prevalence of arthritis and other joint pain diseases. For each market segments covered in global glucosamine market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the glucosamine industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global glucosamine market:

  • Growing awareness about glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the global glucosamine market.
  • North America had the largest revenue share in 2016.
  • Food & beverage is one of the fastest growing application segment.
  • Product launch is the key strategy adopted by the various market players of global glucosamine market.

1 INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

 

2. MARKET OVERVIEW

2.1. GLOBAL GLUCOSAMINE MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES & ANALYSIS

2.8.2. MARKET SHARE ANALYSIS&TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

 

3      MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. GROWING GERIATRIC POPULATION

3.1.2.   ADOPTION OF GLUCOSAMINE IN EMERGING ECONOMIES

3.1.3.   INCREASING ADOPTION OF FOOD & BEVERAGES

3.1.4.   INCREASING PREVALENCE OF ARTHRITIS AND OTHER JOINT PAIN DISEASES

3.1.5. RISING VEGAN DIET POPULATION

3.2. MARKET RESTRAINTS

3.2.1. HIGH COST OF GLUCOSAMINE PRODUCTS

3.2.2. LESS CONSUMPTION IN EMERGING ECONOMIES

3.2.3. STRINGENT REGULATORY RULES TOWARDS FMCG’S

3.3. MARKET OPPORTUNITIES

3.3.1. INCREASING DEMAND IN EMERGING ECONOMIES

3.3.2. AGING POPULATION

3.4.   MARKET CHALLENGES

3.4.1. PROPER DISPOSAL AND RECYCLING TECHNIQUE

3.4.2. LOW AWARENESS OF GLUCOSAMINE MATERIAL IN EMERGING ECONOMIES

3.4.3. TRACEABILITY & CONTROL OF SUPPLY CHAIN

 

4 Global Glucosamine Market BY Type

  MARKET DEFINATION AND SCOPE

  DECISION SUPPORT DATABASE AND ESTIMANTION METHODOLOGY

  COMPARITIVE ANALYASIS ACROSS MARKET SEGMENTS

   OPPORTUITY MATRIX

  4.1.1 GLOBAL GLUCOSAMINE MARKETN-ACETYL-GLUCOSAMINE   MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.2GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE HCL MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

4.1.3GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE SULPHATE MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

 4.1.4GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE ACETYL MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

 4.1.5GLOBAL GLUCOSAMINE MARKETPOLY-N-ACETYL-GLUCOSAMINE (POLY NAG) MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

5 GLOBAL GLUCOSAMINE MARKET BY APPLICATIONS

4.1.         MARKET DEFINITION AND SCOPE

4.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.         OPPORTUNITY MATRIX

4.5.         MARKET SEGMENTATION

   5.1.1 GLOBAL NUTRITIONAL SUPPLEMENTS APPLICATION MARKET

        4.5.1.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.2GLOBAL FOOD AND BEVERAGES APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.3 GLOBAL DAIRY PRODUCTS APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.4 GLOBAL   PHARMACEUTICALS APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.4 GLOBAL FEED ADDITIVES APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

 

8.            COMPETITIVE LANDSCAPE

8.1.         KEY STRATEGIES

8.1.1.     LIST OF MERGERS AND ACQUISITION

8.1.2.     LIST OF JOINT VENTURES

8.1.3.     LIST OF PRODUCT LAUNCHES

8.1.4.     LIST OF PARTNERSHIPS

 

9.4.1.     NORTH AMERICA

9.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.1.2. TOP COUNTRY ANALYSIS

9.4.1.2.1.              U.S.

9.4.1.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.1.3.          KEY CONCLUSIONS

9.4.1.2.2.              CANADA

9.4.1.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.2.3.          KEY CONCLUSIONS

9.4.2.     EUROPE

9.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.2.2. TOP COUNTRY ANALYSIS

9.4.2.2.1.              UK

9.4.2.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.1.3.          KEY CONCLUSIONS

9.4.2.2.2.              FRANCE

9.4.2.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.2.3.          KEY CONCLUSIONS

9.4.2.2.3.              GERMANY

9.4.2.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.3.3.          KEY CONCLUSIONS

9.4.2.2.4.              SPAIN

9.4.2.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.4.3.          KEY CONCLUSIONS

9.4.2.2.5.              REST OF EUROPE

9.4.2.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.5.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.5.3.          KEY CONCLUSIONS

9.4.3.     ASIA PACIFIC

9.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.3.2. TOP COUNTRY ANALYSIS

9.4.3.2.1.              CHINA

9.4.3.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.1.3.          KEY CONCLUSIONS

9.4.3.2.2.              INDIA

9.4.3.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.2.3.          KEY CONCLUSIONS

9.4.3.2.3.              JAPAN

9.4.3.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.3.3.          KEY CONCLUSIONS

9.4.3.2.4.              AUSTRALIA

9.4.3.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.4.3.          KEY CONCLUSIONS

9.4.3.2.5.              REST OF ASIA PACIFIC

9.4.3.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.5.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.5.3.          KEY CONCLUSIONS

9.4.4.     ROW

9.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.4.2. TOP COUNTRY ANALYSIS

9.4.4.2.1.              LATIN AMERICA

9.4.4.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.1.3.          KEY CONCLUSIONS

9.4.4.2.2.              MIDDLE EAST & AFRICA

9.4.4.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.2.3.          KEY CONCLUSIONS

 

10.          COMPANY PROFILES

10.1.      ALFA CHEM (U.S)

10.1.1.  OVERVIEW

10.1.2.  PRODUCT PORTFOLIO

10.1.3.  STRATEGIC INITIATIVES

10.1.4.  SCOT ANALYSIS

10.1.5.  STRATEGIC ANALYSIS

 

10.2 ALCAN CHEMICAL DIVISION

10.2.1        OVERVIEW

10.2.2   PRODUCT PORTFOLIO

10.2.3   STRATEGIC INITIATIVES

10.2.4   SCOT ANALYSIS

10.2.5   STRATEGIC ANALYSIS

 

10.3 CARGILL INC

10.3.1 OVERVIEW

10.3.2   PRODUCT PORTFOLIO

10.3.3   STRATEGIC INITIATIVES

10.3.4   SCOT ANALYSIS

10.3.5   STRATEGIC ANALYSIS

 

10.4 FABRICHEM INC

10.4.1 OVERVIEW

10.4.2   PRODUCT PORTFOLIO

10.4.3   STRATEGIC INITIATIVES

10.4.4   SCOT ANALYSIS

10.4.5   STRATEGIC ANALYSIS

 

10.5 GOLDEN SHELL BIOCHEMICAL CO LTD

10.5.1    OVERVIEW

10.5.2   PRODUCT PORTFOLIO

10.5.3   STRATEGIC INITIATIVES

10.5.4   SCOT ANALYSIS

10.5.5   STRATEGIC ANALYSIS

 

10.6 MARINE BIOCHEMICAL CO LTD

 

10.6.1 OVERVIEW

10.6.2   PRODUCT PORTFOLIO

10.6.3   STRATEGIC INITIATIVES

10.6.4   SCOT ANALYSIS

10.6.5   STRATEGIC ANALYSIS

 

10.7 NAVAMEDIC ASA

10.7.1 OVERVIEW

10.7.2   PRODUCT PORTFOLIO

10.7.3   STRATEGIC INITIATIVES

10.7.4   SCOT ANALYSIS

10.7.5   STRATEGIC ANALYSIS

 

10.8 NUTRACEUTIX INC

 10.8.1 OVERVIEW

10.8.2   PRODUCT PORTFOLIO

10.8.3   STRATEGIC INITIATIVES

10.8.4   SCOT ANALYSIS

10.8.5   STRATEGIC ANALYSIS

 

10.9 KOYO CHEMICAL COMPANY LTD

10.9.1        OVERVIEW

10.9.2   PRODUCT PORTFOLIO

10.9.3   STRATEGIC INITIATIVES

10.9.4   SCOT ANALYSIS

10.9.5   STRATEGIC ANALYSIS

 

10.10 NUTRILITE

10.10.1 OVERVIEW

10.10.2 PRODUCT PORTFOLIO

10.10.3 STRATEGIC INITIATIVES

10.10.4 SCOT ANALYSIS

10.10.5 STRATEGIC ANALYSIS

 

10.11 SCHIFF NUTRITION INTERNATIONAL INC

10.11.1    OVERVIEW

10.11.2 PRODUCT PORTFOLIO

10.11.3 STRATEGIC INITIATIVES

10.11.4 SCOT ANALYSIS

10.11.5 STRATEGIC ANALYSIS

 

10.12   SIMPY SUPPLEMENTS

10.12.1 OVERVIEW

10.12.2 PRODUCT PORTFOLIO

10.12.3 STRATEGIC INITIATIVES

10.12.4 SCOT ANALYSIS

10.12.5 STRATEGIC ANALYSIS

 

10.13 TRIARCO INDUSTRIES INC

10.13.1 OVERVIEW

10.13.2 PRODUCT PORTFOLIO

10.13.3 STRATEGIC INITIATIVES

10.13.4 SCOT ANALYSIS

10.13.5 STRATEGIC ANALYSIS

 

10.14 SYNASIA INC

10.14.1       OVERVIEW

10.14.2 PRODUCT PORTFOLIO

10.14.3 STRATEGIC INITIATIVES

10.14.4 SCOT ANALYSIS

10.14.5 STRATEGIC ANALYSIS

 

10.15 TEVA PHARMACEUTICAL INDUSTRIES LTD.

10.15.1      OVERVIEW

10.15.2 PRODUCT PORTFOLIO

10.15.3 STRATEGIC INITIATIVES

10.15.4 SCOT ANALYSIS

10.15.5 STRATEGIC ANALYSIS

 

LIST OF TABLE

1 GLOBAL GLUCOSAMINE MARKET BY TYPE

2 GLOBAL-ACETYL-GLUCOSAMINE BY GEOGRAPHY 2015-2024 ($ MILLION)

3 GLOBAL GLUCOSAMINE HCL BY GEOGRAPHY 2015-2024 ($ MILLION) 

4 GLOBAL GLUCOSAMINE SULPHATE BY GEOGRAPHY 2015-2024 ($ MILLION) 

5 GLOBALGLUCOSAMINE ACETYL BY GEOGRAPHY 2015-2024 ($ MILLION)

6 GLOBAL POLY-N-ACETYL-GLUCOSAMINE BY GEOGRAPHY 2015-2024 ($ MILLION)

7 GLOBAL GLUCOSAMINE MARKET BY APPLICATIONS

8 GLOBAL NUTRITIONAL SUPPLEMENTS BY GEOGRAPHY 2015-2024 ($ MILLION)

9 GLOBAL FOOD AND BEVERAGES BY GEOGRAPHY 2015-2024 ($ MILLION)

10 GLOBAL DAIRY PRODUCTS BY GEOGRAPHY 2015-2024 ($ MILLION)

11 GLOBAL   PHARMACEUTICALS BY GEOGRAPHY 2015-2024 ($ MILLION)

12 GLOBAL FEED ADDITIVES BY GEOGRAPHY 2015-2024 ($ MILLION)

 

 

 

20.          NORTH AMERICA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

21.          EUROPE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

22.          ASIA PACIFIC GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

23.          REST OF THE WORLD GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

24.          NORTH AMERICA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

25.          EUROPE GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

26.          ASIA PACIFIC GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.          REST OF THE WORLD GLUCOSAMINE MARKET BY APPLCCATION 2015-2024 ($ MILLION)

28.          MARKET BY APPLICATION 2015-2024 ($ MILLION)

29      UNITED STATES GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

30           UNITED STATES GLUCOSAMINE MARKET   BY APPLICATION SIZE 2015-2024 ($ MILLION)

31           CANADA GLUCOSAMINE MARKET BY TYPE2015-2024 ($ MILLION)

32           CANADA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

33          UK GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

47.          UK GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

48      FRANCE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

49           FRANCE GLUCOSAMINE MARKET   BY APPLICATION SIZE 2015-2024 ($ MILLION)

50      GERMANY GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

53.          GERMANY GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

54      SPAIN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

56.          SPAIN GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

57      ROE GLUCOSAMINE MARKET   BY TYPE 2015-2024 ($ MILLION)

59.          ROE GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

60           CHINA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

61           CHINA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

63           INDIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

65.          INDIA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

66           JAPAN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

69.          JAPAN GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

70           AUSTRALIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

71.          AUSTRALIA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

73.          ROAPAC GLUCOSAMINE MARKET BY type 2015-2024 ($ MILLION)

74.          ROAPAC GLUCOSAMINE MARKET BY APPLICAITON SIZE 2015-2024 ($ MILLION)

76.          LATIN AMERICA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

77.          LATIN AMERICA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

79.          MENA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

80.          MENA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

 

lIST OF FIGURE

 

1.            GLOBAL ACETYL-GLUCOSAMINE TYPE MARKET 2015-2024 ($ MILLION)

2.            GLOBALGLUCOSAMINE HCL BY TYPE MARKET 2015-2024 ($ MILLION)

3.            GLOBAL GLUCOSAMINE SULPHATE BY TYPE MARKET 2015-2024 ($ MILLION)

4       GLOBAL GLUCOSAMINE ACETYL BY TYPE MARKET 2015-2024 ($ MILLION)

5.            GLOBAL NUTRITIONAL SUPPLEMENTS TYPE MARKET 2015-2024 ($ MILLION)

6.            GLOBAL FOOD AND BEVERAGES MARKET TYPE 2015-2024 ($ MILLION)

7.            GLOBAL DAIRY PRODUCTS TYPE MARKET 2015-2024 ($ MILLION)

8       GLOBAL PHARMACEUTICALS TYPE MARKET 2015-2024 ($ MILLION)

9       GLOBAL FEED ADDITIVES TYPE MARKET 2015-2024 ($ MILLION)

 

15.          UNITED STATES (U.S.) GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

16.          CANADA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

17.          UNITED KINGDOM (UK) GLUCOSAMINEMARKET 2015-2024 ($ MILLION)

18.          FRANCE GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

19.          GERMANY GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

20.          SPAIN GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

21.          ROE GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

22.          CHINA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

23.          INDIA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

24.          JAPAN GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

25.          AUSTRALIA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

26.          ROAPAC GLUCOSAMINEMARKET 2015-2024 ($ MILLION)

27.          LATIN AMERICA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

28.          MENA GLUCOSAMINE MARKET 2015-2024 ($ MILLION) 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4251116
  • Global Glucosamine Market- Technologies, Market share and Industry Forecast to 2024

  • Publish: November 2016 | Report Code: HPH-4251116

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Glucosamine is an amino derivative of glucose. It is the part of polysaccharides and a basic structure unit of chitin. It is highly used in dietary supplements and pharmaceuticals. The global glucosamine market is expected to have the CAGR of 10.9% during period 2016-2023. There is high prevalence of arthritis and joint pain diseases globally which is highly impacting the glucosamine market as glucosamine is an important ingredient of the medicine used for treating joint pain and arthritis diseases. So the rising cases of arthritis diseases will increase the demand for medicines which positively impact the glucosamine market. According to the World Health Organization there are 9.6% of men and 18.0% of women who are aged above 60 years are suffering from symptomatic arthritis. Rising geriatric population is the prime factor driving global glucosamine market for the forecast period. National Institute of Health’s report, An Aging World 2015, estimated the world’s geriatric population (aged 65 and over) to be 8.5% in 2015. The report predicts geriatric population to reach around 17% by 2050.  Men and women above 65 years tend to suffer from arthritis and other joint pain diseases. By the year 2040, more than 78 million people aged 18 years and above will suffer from one or other form of Osteoarthritis (OA). Expenditures towards OA treatment for US government alone costs approx. $62.1billion every year.

Proper disposal and recycling technique, low awareness of glucosamine material in emerging economies, and traceability & control of supply chain are the challenges faced by the key market players in the glucosamine market. Majority doctors prescribe glucosamine to regulate OA disease. Emerging economies like India and China are increasing investments for preventive healthcare for the forecasted period. The glucosamine market is segmented in terms of applications. Dairy product is among the known common application of glucosamine. Glucosamine in dairy products market are estimated to reach $57million by 2020, at CAGR 15%. By 2025, countries like India, Pakistan, US, and China will be leading producers of milk and dairy products growing at 3 % annually.

 

Source: OBRC Analysis

The research report is segmented on the basis of type and applications. On the basis of type, the market segmented into:

  • N- acetyl glucosamine,
  • Glucosamine HCL ,
  • Glucosamine Sulphate ,
  • Glucosamine Acetyl
  • Poly-N-Acetyl-Glucosamine (Poly NAG)  







Under application, the research report is segmented into:

  • Nutritional Supplements
  • Food & Beverage
  • Dairy Products
  • Feed Additives
  • Pharmaceuticals






Food & beverage is one of the fastest rising application segments. Europe and Asia Pacific are the leading regions in food & beverage market. The global demand in food & beverage is expected to have the CAGR of 15% (11,700tons) by 2020. Japan is the fastest rising consumer market for glucosamine in food and beverage. Japan has over 26% of its total population aged 65 years and above. Geriatric population in Japan is estimated to increase at 4% per annum. Glucosamine market in Japan is growing at CAGR 17% till 2020. Nutritional supplement was leading application segment of glucosamine in the world with market share of 35% in 2015. The nutritional supplement market is growing fastest in US. US accounted for the largest market share (of 71%) in North America for glucosamine. Growing geriatric population and health conscious working people are the contributing factors towards nutritional supplement market growth. Nutritional supplement market share of North America was 27% in 2015. Asia Pacific is expected to have the fastest growth rate  for nutritional supplement with CAGR of 12.5% by 2022. Increasing geriatric population in China, Japan, and Australia are the main drivers of nutritional supplement market in Asia Pacific.

The revenue for the above application  segments are specific to the global glucosamine market. however, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type segment. Region wise the glucosamine market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World.





North America dominated the glucosamine market with market share of 32% in 2015. North America is followed closely by Europe with market share of 29% in 2015. Awareness regarding glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the market in North America and Europe for the forecast period. Asia Pacific is the fastest growing glucosamine market for the forecast period and is expected to have market share of 34% by 2022. In 2015, Asia Pacific had over 38% of the world’s total geriatric population. Every five years geriatric population in Asia Pacific grows at 22%. Increasing geriatric population, increasing health conscious working people, rising adoption of food & beverage, and growing vegan population are the factors driving glucosamine market in Asia Pacific for the forecasted period. Geriatric population in India is estimated to increase up to 3.75% by 2021. Countries like Japan, India, China, Indonesia and Vietnam are among the growing markets for glucosamine in Asia Pacific. Nutritional supplements demand is growing in India, with growing awareness among working youth population. Food Safety and Standards Act 2006 and Food & Drug Administration’s Orphan Drug Act Amendments 1988 are the reference points for regulations for food products including nutritional supplements to be sold in the country.

The major market players of the global glucosamine market are:

  • ALFA CHEM,
  • CARGILL INC.
  • FABRICHEM INC.
  • GOLDEN SHELL BIOCHEMICAL CO LTD.
  • KOYO CHEMICAL COMPANY LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.







Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in glucosamine market, to increase their global presence. Example: Frutarom Inc., bought 100% shares of nutritional supplement manufacturer, Grow Company Inc., US, for $20million on 18th January 2016.

On 29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF world’s first non-shellfish glucosamine product. TSI Group Co Ltd has their presence in Europe and North America.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch that is on29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF worlds first non-shellfish glucosamine product
  • Provide in detail description about segments which affect the global glucosamine market.
  • Provide you the patent analysis of the global glucosamine market.
  • Identify and understand the strengths, opportunities, challenges and threats of the glucosamine market.
  • Provide revenues of major players of the market such as Alfa Chem, Cargill Inc, Teva Pharmaceutical Industries Ltd.
  • Provide you various regulatory policies which affect the global glucosamine market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global glucosamin market offers the longest chain of market segmentation covering major market segmentation based on application and type. The report tracks the major market trends in the global glucosamine market such as increasing prevalence of arthritis and other joint pain diseases. For each market segments covered in global glucosamine market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the glucosamine industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global glucosamine market:

  • Growing awareness about glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the global glucosamine market.
  • North America had the largest revenue share in 2016.
  • Food & beverage is one of the fastest growing application segment.
  • Product launch is the key strategy adopted by the various market players of global glucosamine market.

1 INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

 

2. MARKET OVERVIEW

2.1. GLOBAL GLUCOSAMINE MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES & ANALYSIS

2.8.2. MARKET SHARE ANALYSIS&TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

 

3      MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. GROWING GERIATRIC POPULATION

3.1.2.   ADOPTION OF GLUCOSAMINE IN EMERGING ECONOMIES

3.1.3.   INCREASING ADOPTION OF FOOD & BEVERAGES

3.1.4.   INCREASING PREVALENCE OF ARTHRITIS AND OTHER JOINT PAIN DISEASES

3.1.5. RISING VEGAN DIET POPULATION

3.2. MARKET RESTRAINTS

3.2.1. HIGH COST OF GLUCOSAMINE PRODUCTS

3.2.2. LESS CONSUMPTION IN EMERGING ECONOMIES

3.2.3. STRINGENT REGULATORY RULES TOWARDS FMCG’S

3.3. MARKET OPPORTUNITIES

3.3.1. INCREASING DEMAND IN EMERGING ECONOMIES

3.3.2. AGING POPULATION

3.4.   MARKET CHALLENGES

3.4.1. PROPER DISPOSAL AND RECYCLING TECHNIQUE

3.4.2. LOW AWARENESS OF GLUCOSAMINE MATERIAL IN EMERGING ECONOMIES

3.4.3. TRACEABILITY & CONTROL OF SUPPLY CHAIN

 

4 Global Glucosamine Market BY Type

  MARKET DEFINATION AND SCOPE

  DECISION SUPPORT DATABASE AND ESTIMANTION METHODOLOGY

  COMPARITIVE ANALYASIS ACROSS MARKET SEGMENTS

   OPPORTUITY MATRIX

  4.1.1 GLOBAL GLUCOSAMINE MARKETN-ACETYL-GLUCOSAMINE   MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.1.2GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE HCL MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

4.1.3GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE SULPHATE MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

 4.1.4GLOBAL GLUCOSAMINE MARKETGLUCOSAMINE ACETYL MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

 4.1.5GLOBAL GLUCOSAMINE MARKETPOLY-N-ACETYL-GLUCOSAMINE (POLY NAG) MARKET

4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3. KEY PLAYERS & KEY PRODUCTS

4.5.2.4. KEY CONCLUSIONS

5 GLOBAL GLUCOSAMINE MARKET BY APPLICATIONS

4.1.         MARKET DEFINITION AND SCOPE

4.2.         DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.         COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.         OPPORTUNITY MATRIX

4.5.         MARKET SEGMENTATION

   5.1.1 GLOBAL NUTRITIONAL SUPPLEMENTS APPLICATION MARKET

        4.5.1.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.2GLOBAL FOOD AND BEVERAGES APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.3 GLOBAL DAIRY PRODUCTS APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.4 GLOBAL   PHARMACEUTICALS APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

5.1.4 GLOBAL FEED ADDITIVES APPLICATION MARKET

4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3. KEY PLAYERS & KEY PRODUCTS

4.5.1.4. KEY CONCLUSIONS

 

8.            COMPETITIVE LANDSCAPE

8.1.         KEY STRATEGIES

8.1.1.     LIST OF MERGERS AND ACQUISITION

8.1.2.     LIST OF JOINT VENTURES

8.1.3.     LIST OF PRODUCT LAUNCHES

8.1.4.     LIST OF PARTNERSHIPS

 

9.4.1.     NORTH AMERICA

9.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.1.2. TOP COUNTRY ANALYSIS

9.4.1.2.1.              U.S.

9.4.1.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.1.3.          KEY CONCLUSIONS

9.4.1.2.2.              CANADA

9.4.1.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.1.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.1.2.2.3.          KEY CONCLUSIONS

9.4.2.     EUROPE

9.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.2.2. TOP COUNTRY ANALYSIS

9.4.2.2.1.              UK

9.4.2.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.1.3.          KEY CONCLUSIONS

9.4.2.2.2.              FRANCE

9.4.2.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.2.3.          KEY CONCLUSIONS

9.4.2.2.3.              GERMANY

9.4.2.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.3.3.          KEY CONCLUSIONS

9.4.2.2.4.              SPAIN

9.4.2.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.4.3.          KEY CONCLUSIONS

9.4.2.2.5.              REST OF EUROPE

9.4.2.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.2.2.5.2.          KEY PLAYERS & KEY PRODUCTS

9.4.2.2.5.3.          KEY CONCLUSIONS

9.4.3.     ASIA PACIFIC

9.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.3.2. TOP COUNTRY ANALYSIS

9.4.3.2.1.              CHINA

9.4.3.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.1.3.          KEY CONCLUSIONS

9.4.3.2.2.              INDIA

9.4.3.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.2.3.          KEY CONCLUSIONS

9.4.3.2.3.              JAPAN

9.4.3.2.3.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.3.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.3.3.          KEY CONCLUSIONS

9.4.3.2.4.              AUSTRALIA

9.4.3.2.4.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.4.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.4.3.          KEY CONCLUSIONS

9.4.3.2.5.              REST OF ASIA PACIFIC

9.4.3.2.5.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.3.2.5.2.          KEY PLAYERS & KEY PRODUCTS

9.4.3.2.5.3.          KEY CONCLUSIONS

9.4.4.     ROW

9.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

9.4.4.2. TOP COUNTRY ANALYSIS

9.4.4.2.1.              LATIN AMERICA

9.4.4.2.1.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.1.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.1.3.          KEY CONCLUSIONS

9.4.4.2.2.              MIDDLE EAST & AFRICA

9.4.4.2.2.1.          MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

9.4.4.2.2.2.          KEY PLAYERS & KEY PRODUCTS

9.4.4.2.2.3.          KEY CONCLUSIONS

 

10.          COMPANY PROFILES

10.1.      ALFA CHEM (U.S)

10.1.1.  OVERVIEW

10.1.2.  PRODUCT PORTFOLIO

10.1.3.  STRATEGIC INITIATIVES

10.1.4.  SCOT ANALYSIS

10.1.5.  STRATEGIC ANALYSIS

 

10.2 ALCAN CHEMICAL DIVISION

10.2.1        OVERVIEW

10.2.2   PRODUCT PORTFOLIO

10.2.3   STRATEGIC INITIATIVES

10.2.4   SCOT ANALYSIS

10.2.5   STRATEGIC ANALYSIS

 

10.3 CARGILL INC

10.3.1 OVERVIEW

10.3.2   PRODUCT PORTFOLIO

10.3.3   STRATEGIC INITIATIVES

10.3.4   SCOT ANALYSIS

10.3.5   STRATEGIC ANALYSIS

 

10.4 FABRICHEM INC

10.4.1 OVERVIEW

10.4.2   PRODUCT PORTFOLIO

10.4.3   STRATEGIC INITIATIVES

10.4.4   SCOT ANALYSIS

10.4.5   STRATEGIC ANALYSIS

 

10.5 GOLDEN SHELL BIOCHEMICAL CO LTD

10.5.1    OVERVIEW

10.5.2   PRODUCT PORTFOLIO

10.5.3   STRATEGIC INITIATIVES

10.5.4   SCOT ANALYSIS

10.5.5   STRATEGIC ANALYSIS

 

10.6 MARINE BIOCHEMICAL CO LTD

 

10.6.1 OVERVIEW

10.6.2   PRODUCT PORTFOLIO

10.6.3   STRATEGIC INITIATIVES

10.6.4   SCOT ANALYSIS

10.6.5   STRATEGIC ANALYSIS

 

10.7 NAVAMEDIC ASA

10.7.1 OVERVIEW

10.7.2   PRODUCT PORTFOLIO

10.7.3   STRATEGIC INITIATIVES

10.7.4   SCOT ANALYSIS

10.7.5   STRATEGIC ANALYSIS

 

10.8 NUTRACEUTIX INC

 10.8.1 OVERVIEW

10.8.2   PRODUCT PORTFOLIO

10.8.3   STRATEGIC INITIATIVES

10.8.4   SCOT ANALYSIS

10.8.5   STRATEGIC ANALYSIS

 

10.9 KOYO CHEMICAL COMPANY LTD

10.9.1        OVERVIEW

10.9.2   PRODUCT PORTFOLIO

10.9.3   STRATEGIC INITIATIVES

10.9.4   SCOT ANALYSIS

10.9.5   STRATEGIC ANALYSIS

 

10.10 NUTRILITE

10.10.1 OVERVIEW

10.10.2 PRODUCT PORTFOLIO

10.10.3 STRATEGIC INITIATIVES

10.10.4 SCOT ANALYSIS

10.10.5 STRATEGIC ANALYSIS

 

10.11 SCHIFF NUTRITION INTERNATIONAL INC

10.11.1    OVERVIEW

10.11.2 PRODUCT PORTFOLIO

10.11.3 STRATEGIC INITIATIVES

10.11.4 SCOT ANALYSIS

10.11.5 STRATEGIC ANALYSIS

 

10.12   SIMPY SUPPLEMENTS

10.12.1 OVERVIEW

10.12.2 PRODUCT PORTFOLIO

10.12.3 STRATEGIC INITIATIVES

10.12.4 SCOT ANALYSIS

10.12.5 STRATEGIC ANALYSIS

 

10.13 TRIARCO INDUSTRIES INC

10.13.1 OVERVIEW

10.13.2 PRODUCT PORTFOLIO

10.13.3 STRATEGIC INITIATIVES

10.13.4 SCOT ANALYSIS

10.13.5 STRATEGIC ANALYSIS

 

10.14 SYNASIA INC

10.14.1       OVERVIEW

10.14.2 PRODUCT PORTFOLIO

10.14.3 STRATEGIC INITIATIVES

10.14.4 SCOT ANALYSIS

10.14.5 STRATEGIC ANALYSIS

 

10.15 TEVA PHARMACEUTICAL INDUSTRIES LTD.

10.15.1      OVERVIEW

10.15.2 PRODUCT PORTFOLIO

10.15.3 STRATEGIC INITIATIVES

10.15.4 SCOT ANALYSIS

10.15.5 STRATEGIC ANALYSIS

 

LIST OF TABLE

1 GLOBAL GLUCOSAMINE MARKET BY TYPE

2 GLOBAL-ACETYL-GLUCOSAMINE BY GEOGRAPHY 2015-2024 ($ MILLION)

3 GLOBAL GLUCOSAMINE HCL BY GEOGRAPHY 2015-2024 ($ MILLION) 

4 GLOBAL GLUCOSAMINE SULPHATE BY GEOGRAPHY 2015-2024 ($ MILLION) 

5 GLOBALGLUCOSAMINE ACETYL BY GEOGRAPHY 2015-2024 ($ MILLION)

6 GLOBAL POLY-N-ACETYL-GLUCOSAMINE BY GEOGRAPHY 2015-2024 ($ MILLION)

7 GLOBAL GLUCOSAMINE MARKET BY APPLICATIONS

8 GLOBAL NUTRITIONAL SUPPLEMENTS BY GEOGRAPHY 2015-2024 ($ MILLION)

9 GLOBAL FOOD AND BEVERAGES BY GEOGRAPHY 2015-2024 ($ MILLION)

10 GLOBAL DAIRY PRODUCTS BY GEOGRAPHY 2015-2024 ($ MILLION)

11 GLOBAL   PHARMACEUTICALS BY GEOGRAPHY 2015-2024 ($ MILLION)

12 GLOBAL FEED ADDITIVES BY GEOGRAPHY 2015-2024 ($ MILLION)

 

 

 

20.          NORTH AMERICA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

21.          EUROPE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

22.          ASIA PACIFIC GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

23.          REST OF THE WORLD GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

24.          NORTH AMERICA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

25.          EUROPE GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

26.          ASIA PACIFIC GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

27.          REST OF THE WORLD GLUCOSAMINE MARKET BY APPLCCATION 2015-2024 ($ MILLION)

28.          MARKET BY APPLICATION 2015-2024 ($ MILLION)

29      UNITED STATES GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

30           UNITED STATES GLUCOSAMINE MARKET   BY APPLICATION SIZE 2015-2024 ($ MILLION)

31           CANADA GLUCOSAMINE MARKET BY TYPE2015-2024 ($ MILLION)

32           CANADA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

33          UK GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

47.          UK GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

48      FRANCE GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

49           FRANCE GLUCOSAMINE MARKET   BY APPLICATION SIZE 2015-2024 ($ MILLION)

50      GERMANY GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

53.          GERMANY GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

54      SPAIN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

56.          SPAIN GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

57      ROE GLUCOSAMINE MARKET   BY TYPE 2015-2024 ($ MILLION)

59.          ROE GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

60           CHINA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

61           CHINA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

63           INDIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

65.          INDIA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

66           JAPAN GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

69.          JAPAN GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

70           AUSTRALIA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

71.          AUSTRALIA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

73.          ROAPAC GLUCOSAMINE MARKET BY type 2015-2024 ($ MILLION)

74.          ROAPAC GLUCOSAMINE MARKET BY APPLICAITON SIZE 2015-2024 ($ MILLION)

76.          LATIN AMERICA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

77.          LATIN AMERICA GLUCOSAMINE MARKET BY APPLICATION SIZE 2015-2024 ($ MILLION)

79.          MENA GLUCOSAMINE MARKET BY TYPE 2015-2024 ($ MILLION)

80.          MENA GLUCOSAMINE MARKET BY APPLICATION 2015-2024 ($ MILLION)

 

lIST OF FIGURE

 

1.            GLOBAL ACETYL-GLUCOSAMINE TYPE MARKET 2015-2024 ($ MILLION)

2.            GLOBALGLUCOSAMINE HCL BY TYPE MARKET 2015-2024 ($ MILLION)

3.            GLOBAL GLUCOSAMINE SULPHATE BY TYPE MARKET 2015-2024 ($ MILLION)

4       GLOBAL GLUCOSAMINE ACETYL BY TYPE MARKET 2015-2024 ($ MILLION)

5.            GLOBAL NUTRITIONAL SUPPLEMENTS TYPE MARKET 2015-2024 ($ MILLION)

6.            GLOBAL FOOD AND BEVERAGES MARKET TYPE 2015-2024 ($ MILLION)

7.            GLOBAL DAIRY PRODUCTS TYPE MARKET 2015-2024 ($ MILLION)

8       GLOBAL PHARMACEUTICALS TYPE MARKET 2015-2024 ($ MILLION)

9       GLOBAL FEED ADDITIVES TYPE MARKET 2015-2024 ($ MILLION)

 

15.          UNITED STATES (U.S.) GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

16.          CANADA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

17.          UNITED KINGDOM (UK) GLUCOSAMINEMARKET 2015-2024 ($ MILLION)

18.          FRANCE GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

19.          GERMANY GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

20.          SPAIN GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

21.          ROE GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

22.          CHINA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

23.          INDIA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

24.          JAPAN GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

25.          AUSTRALIA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

26.          ROAPAC GLUCOSAMINEMARKET 2015-2024 ($ MILLION)

27.          LATIN AMERICA GLUCOSAMINE MARKET 2015-2024 ($ MILLION)

28.          MENA GLUCOSAMINE MARKET 2015-2024 ($ MILLION) 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion